Abbott Labs must be getting a bad case of heartburn after acquiring St. Jude Medical in January. The Chicago-based medical device company got a warning letter from the Food and Drug Administration this week that detailed years of St. Jude’s failures to fix scary — and even deadly — defects in its implantable heart devices....
read more
Source: New York Post